A recombinant Drosophila acetylcholinesterase mutant, its preparation method and application

By mutating the amino acid sequence of Drosophila acetylcholinesterase and optimizing the Escherichia coli expression system, a highly active and stable recombinant acetylcholinesterase was prepared, overcoming the shortcomings of existing acetylcholinesterase preparation technologies and achieving efficient detection of pesticide residues.

CN117305275BActive Publication Date: 2026-11-17SOUTH CHINA UNIV OF TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311245248.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-26
Publication Date
2026-11-17
Estimated Expiration
2043-09-26

AI Technical Summary

Technical Problem

Existing technologies for the preparation of acetylcholinesterase suffer from problems such as low sensitivity, poor stability, complex purification processes, low yield, and low expression levels. In particular, in the Escherichia coli prokaryotic expression system, the solubility and activity of Drosophila acetylcholinesterase are insufficient, making it difficult to meet the needs of pesticide residue detection.

Method used

By mutating 38 amino acid sites in the amino acid sequence of Drosophila acetylcholinesterase and optimizing the codons of the Escherichia coli expression system, a recombinant acetylcholinesterase mutant was constructed. The mutant was then induced to express using the Escherichia coli prokaryotic expression system and purified by nickel ion affinity chromatography to obtain a highly active and soluble recombinant acetylcholinesterase.

Benefits of technology

It improves the activity and stability of recombinant acetylcholinesterase, enhances its sensitivity to organophosphorus and carbamate pesticides, makes it suitable for industrial production, and can be used for qualitative and quantitative detection of pesticide residues.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117305275B_ABST
    Figure CN117305275B_ABST
Patent Text Reader

Abstract

This invention discloses a recombinant Drosophila acetylcholinesterase mutant, its preparation method, and its applications. The method involves transforming a recombinant expression vector containing the DNA molecule encoding the recombinant Drosophila acetylcholinesterase mutant as shown in SEQ ID NO.1 into engineered E. coli SHuffle T7 cells, followed by induced expression. The recombinant Drosophila acetylcholinesterase mutant expressed by this method possesses the activity of wild-type Drosophila acetylcholinesterase, and its enzymatic properties are similar to the wild type. Its pH and thermostability are enhanced, and the enzyme activity yield increases from 28.73 U / L fermentation broth to 147.36 U / L fermentation broth, approximately five times that of the wild type. The method described in this invention is simple and efficient, uses readily available raw materials, is easy to separate and purify, and is suitable for large-scale expression, making it suitable for industrial production and possessing broad application prospects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of biotechnology, specifically relating to a recombinant fruit fly acetylcholinesterase mutant, its preparation method, and its application. Background Technology

[0002] Pesticide residues refer to the residues of pesticides that have not been decomposed or degraded within a certain environmental range after application, remaining in soil, water, air, organisms, and harvested crops in the form of trace amounts of the pesticide itself, toxic metabolites, degradation products, and other transformation products. Currently, due to the increased scope and frequency of pesticide use, pesticide residue problems are gradually becoming a serious challenge threatening nature and human health. Considering factors such as sensitivity, specificity, accuracy, and cost, enzyme inhibition methods are the most widely used detection method for pesticide residues. This method is mainly based on the sensitivity between pesticides and enzyme molecules; for the detection of organophosphorus and carbamate pesticides, acetylcholinesterase is often selected.

[0003] Acetylcholinesterase (AChE) is a serine hydrolase widely distributed in various plants and animals, primarily found in neurons and neuromuscular junctions, where it performs its catalytic function in the synaptic cleft. It exhibits high catalytic specificity for acetylcholine and very high catalytic activity; each acetylcholinesterase molecule can degrade approximately 25,000 acetylcholine molecules per second.

[0004] Currently, there are two main methods for preparing acetylcholinesterase: natural extraction and recombinant expression. Acetylcholinesterase obtained through natural extraction suffers from low sensitivity, poor stability, complex purification processes, low yields, and limited applications. Therefore, the preparation of acetylcholinesterase using recombinant expression technology is a current research hotspot.

[0005] Among the mainstream heterologous recombination expression systems, the insect baculovirus expression system has high expression costs and low protein expression levels, making it difficult to mass-produce; the Pichia pastoris expression system has a long fermentation cycle and is cumbersome to operate; the Escherichia coli expression system has high expression levels, short cycles, and low costs, but due to the lack of a similar glycosylation modification process, its codon bias also varies greatly, making it difficult to express acetylcholinesterase using the E. coli prokaryotic expression system, and the expression products are unstable.

[0006] The inhibition parameters of acetylcholinesterase from different organisms were measured using various organophosphorus and carbamate pesticides. The results showed that acetylcholinesterase from *Drosophila melanogaster* was significantly more sensitive to different pesticides than that from other sources. However, the prokaryotic expression of *Drosophila melanogaster* acetylcholinesterase in *E. coli* suffers from poor solubility and low activity. Therefore, it is necessary to molecularly modify acetylcholinesterase to improve its solubility and activity, enabling its application in industrial production. Summary of the Invention

[0007] To address these issues, the primary objective of this invention is to provide a highly active recombinant acetylcholinesterase mutant; the recombinant acetylcholinesterase mutant exhibits significantly enhanced enzyme activity.

[0008] A second objective of this invention is to provide a method for preparing the above-mentioned highly active recombinant acetylcholinesterase mutant.

[0009] A third objective of this invention is to provide the application of the above-mentioned highly active recombinant acetylcholinesterase mutant.

[0010] The technical solution adopted by this invention to solve its technical problem is as follows:

[0011] A highly active recombinant acetylcholinesterase mutant, whose amino acid sequence is shown in SEQ ID NO.1, has 38 amino acid mutations compared with the Drosophila melanogaster amino acid sequence (Drosophila melanogaster, Genbank number: NP_476953.1, i.e. SEQ ID NO.3) in the NCBI database.

[0012] The aforementioned biological materials related to recombinant acetylcholinesterase mutants are any one or more combinations of the following biological materials:

[0013] 1) The DNA molecule encoding the recombinant acetylcholinesterase mutant described above;

[0014] 2) An expression cassette containing the DNA molecule described in 1);

[0015] 3) A recombinant expression vector containing the DNA molecule described in 1), or a recombinant expression vector containing the expression cassette described in 2);

[0016] 4) A recombinant engineered cell line containing the DNA molecule described in 1), or a recombinant engineered cell line containing the expression cassette described in 2), or a recombinant engineered cell line containing the recombinant expression vector described in 3).

[0017] The preferred nucleotide sequence of the DNA molecule described in 1) is as shown in SEQ ID NO.2. This nucleotide sequence has been optimized for codons based on the *E. coli* expression system, which can significantly improve the expression efficiency of heterologous genes in the host bacterium.

[0018] The above-mentioned method for preparing a highly active recombinant acetylcholinesterase mutant (i.e., a highly efficient expression method for acetylcholinesterase) involves transforming a recombinant expression vector containing a DNA molecule encoding the recombinant Drosophila acetylcholinesterase mutant into engineered cells, followed by induced expression, solid-liquid separation to collect the cell precipitate, and purification to obtain a highly active recombinant Drosophila acetylcholinesterase mutant.

[0019] The DNA molecule sequence is preferably a sequence in which the codons have been optimized based on the E. coli expression system; more preferably, it is shown in SEQ ID NO.2.

[0020] The backbone vector of the recombinant expression vector is preferably a prokaryotic expression vector; more preferably a pET series vector; and most preferably pET-32a.

[0021] The engineered cells are preferably Escherichia coli cells; more preferably SHuffle T7 cells.

[0022] The induced expression includes the following steps:

[0023] (1) Take the recombinant engineered cell line, inoculate it into LB liquid medium and culture it to obtain the recombinant engineered cell seed solution;

[0024] (2) The obtained seed culture was inoculated into LB liquid medium and cultured with shaking until the bacterial culture reached OD. 600 =0.6~0.8;

[0025] (3) Add IPTG to the obtained bacterial culture to a final concentration of 0.05-1 mmol / L to induce the cells to express the target protein. Centrifuge and collect the bacterial precipitate. The obtained bacterial precipitate contains the recombinant acetylcholinesterase.

[0026] The LB liquid culture medium is preferably an LB culture medium containing 100 μg / mL ampicillin.

[0027] The preferred culture conditions described in step (1) are shaking culture; more preferably, shaking culture at 37°C overnight.

[0028] The preferred ratio of the recombinant engineered cell seed solution and LB medium in step (2) is 1:100 (volume ratio).

[0029] The preferred conditions for the shaking culture in step (2) are a temperature of 35-38°C and a rotation speed of 150-200 r / min; more preferably, a temperature of 37°C and a rotation speed of 180 r / min.

[0030] In step (3), the final concentration of the inducing agent IPTG is preferably 0.6 mmol / L, which is 0.05 to 1 mmol / L.

[0031] The induction conditions described in step (3) are preferably induced at 18-37°C for 16-24 hours; more preferably induced at 18°C ​​for 18 hours.

[0032] The centrifugation conditions described in step (3) are preferably centrifuged at 3000-5000g for 20-40 minutes at 4°C; more preferably, centrifuged at 4000g for 30 minutes at 4°C.

[0033] The purification process includes the following steps:

[0034] (4) Add lysis buffer to the obtained bacterial pellet and shake to resuspend the bacterial pellet;

[0035] (5) The obtained resuspension was ultrasonically treated and centrifuged to remove the precipitate, and the supernatant was obtained.

[0036] (6) The supernatant was filtered using a microporous membrane with a pore size of 0.22 μm;

[0037] (7) The target protein was purified by nickel ion affinity chromatography and the eluent was collected to obtain a highly active recombinant Drosophila acetylcholinesterase mutant.

[0038] The preferred formulation of the lysis buffer in step (4) is: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5.

[0039] The preferred ratio of the bacterial cell precipitation and lysis buffer in step (4) is 1g:5-10mL by mass volume; more preferably, it is 1g:5mL.

[0040] The preferred conditions for ultrasonic treatment in step (5) are: power 100-250W, ultrasonic treatment for 1-4 seconds, interval for 1-4 seconds, and duration for 20-30 minutes; more preferably, power 150W, ultrasonic treatment for 3 seconds, interval for 3 seconds, and duration for 30 minutes.

[0041] The centrifugation conditions described in step (5) are preferably 10,000 to 15,000 g centrifugation at 4°C for 20 to 40 min; more preferably 12,000 g centrifugation at 4°C for 30 min.

[0042] The preferred formulation of the equilibration buffer used in the nickel ion affinity chromatography in step (6) is: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5.

[0043] The preferred elution buffer formulation for nickel ion affinity chromatography in step (6) is: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4 and 500 mmol / L imidazole; pH 7.5.

[0044] The application of the above-mentioned highly active recombinant acetylcholinesterase mutant in pesticide residue detection.

[0045] The detection method is preferably qualitative and / or quantitative.

[0046] The pesticides mentioned are preferably organophosphorus pesticides and / or carbamate pesticides; more preferably, dimethoate, dichlorvos, malathion, trichlorfon, methomyl, or methamidophos. Organophosphorus pesticides or carbamate pesticides can bind to the hydroxyl group on the serine residue of the active site of acetylcholinesterase, causing phosphorylation or formylation of the enzyme, thus losing its ability to reactivate and preventing the binding of the enzyme molecule to the substrate. Changes in enzyme activity can be detected, thereby enabling qualitative and quantitative detection of pesticide residues.

[0047] The application includes the following steps: adding the recombinant acetylcholinesterase mutant to the sample to be tested, incubating, adding Ellman substrate chromogenic solution after incubation, and measuring the activity using an enzyme-linked immunosorbent assay (ELISA) reader; and qualitatively and / or quantitatively detecting pesticide residues by comparing the changes in enzyme activity before and after the reaction.

[0048] The preferred incubation temperature is 37°C.

[0049] The present invention has the following advantages and effects compared with the prior art:

[0050] 1. This invention uses a prokaryotic expression method of Escherichia coli to prepare a soluble and highly active recombinant acetylcholinesterase. The separation and purification only requires one affinity chromatography step, which is simple, efficient, easy to express in large quantities, and suitable for industrial production.

[0051] 2. Based on codon optimization of the prokaryotic expression system, this invention mutates 38 amino acid sites in the amino acid sequence of wild-type Drosophila acetylcholinesterase. The mutant retains the activity of wild-type Drosophila acetylcholinesterase while improving the enzyme activity of recombinant expression.

[0052] 3. The Drosophila acetylcholinesterase mutant expressed by the Escherichia coli prokaryotic expression system of this invention has enzymatic properties similar to the wild type, with enhanced pH and thermal stability, as well as good storage stability. It also has strong sensitivity to a variety of organophosphorus and carbamate pesticides and can be used for the residue detection of such pesticides. Attached Figure Description

[0053] Figure 1 This is a PCR amplification diagram of the recombinant Drosophila acetylcholinesterase DNA molecule; in the diagram, lane M is the DNA Marker, and lanes 1-2 are the PCR amplification products of the Drosophila acetylcholinesterase DNA molecule.

[0054] Figure 2 This is an SDS-PAGE image of recombinant Drosophila acetylcholinesterase expression; lane M is the pre-stained protein marker; lanes 1-5 are, in order, total protein, supernatant protein, precipitate, penetrating protein, and eluted protein;

[0055] Figure 3 Figure showing the effect of pH on the activity of acetylcholinesterase in wild-type and mutant recombinant Drosophila;

[0056] Figure 4 Figure showing the effect of temperature on the activity of acetylcholinesterase in wild-type and mutant recombinant Drosophila;

[0057] Figure 5 The graph shows the pH stability changes of acetylcholinesterase in wild-type and mutant recombinant Drosophila.

[0058] Figure 6 Figure showing the changes in the thermostability of acetylcholinesterase in wild-type and mutant recombinant Drosophila;

[0059] Figure 7 A graph showing the changes in storage stability of the recombinant Drosophila acetylcholinesterase mutant;

[0060] Figure 8 This is a comparison chart of the total enzyme activity of recombinant Drosophila acetylcholinesterase before and after optimization and mutation. Detailed Implementation

[0061] The present invention will be further described in detail below with reference to the embodiments and accompanying drawings. However, the embodiments are used only to illustrate the present invention and are not intended to limit the scope of the present invention.

[0062] Unless otherwise specified, all reagents and raw materials used in this invention are commercially available products or products that can be prepared by known methods.

[0063] Example 1: Construction of a recombinant vector containing a nucleotide sequence encoding a recombinant Drosophila acetylcholinesterase mutant.

[0064] (1) Constructing a recombinant vector containing a nucleotide sequence encoding a recombinant Drosophila acetylcholinesterase mutant, including the following steps:

[0065] Based on the amino acid sequence (SEQ ID NO.1) of the recombinant Drosophila acetylcholinesterase mutant, the DNA molecule encoding the Drosophila acetylcholinesterase mutant was artificially synthesized using a two-round PCR method. Specific PCR results are shown below. Figure 1 As shown, the sequence is as shown in SEQ ID NO.3.

[0066] (2) Homologous recombination was then used to ligate the DNA molecule of the Drosophila acetylcholinesterase mutant with the plasmid to construct a recombinant vector. The DNA molecule from (1) and the linearized pET-32a plasmid were used as templates, and 5 μL of Hipro DNAAssembly Mix and an appropriate amount of sterile water were added for homologous recombination ligation. The reaction conditions were: 50℃ for 15 min. The ligation product was transformed into DH5α competent cells.

[0067] (3) Select a single colony for colony PCR identification, and extract plasmids from positive single clones after culturing. Send the plasmids to a sequencing company for sequencing verification to confirm the correctness of the DNA molecule encoding the recombinant Drosophila acetylcholinesterase mutant. This will successfully construct a recombinant vector containing the DNA molecule encoding the recombinant Drosophila acetylcholinesterase mutant.

[0068] The amino acid sequence of recombinant Drosophila acetylcholinesterase (SEQ ID NO.1, underlined amino acids):

[0069] MAISCRQSRVLPMSLPLPLTIPLPLVLVLSLHLSGVCGVIDRLVVQTSSGPVRGRSVTVQGREVHVYTGIPYAKPPV G DLRFRKPVPAEPWHGVLDAT K L PN TCVQERYEYFPGF P GEE M WNPNTNVSEDCLYINVWAPAKARLRHGRGANGGEHPNGKQADTDHLIHNGNPQNTTNGLPILIWIYGGGFMTGSATLDIYNADIMAAVGNVIVASFQYRVGAFGFLHLAPEMP P EFAEEAPGNVGLWDQALAIRWLKDNAHAFGNPEW I TLFGESAGSSSVNAQL L SPVTRGLVKRG I MQSGTMNAPWSHMTSE EAVEI A KALINDCNCNASMLKTNPAHVMSCMRSVD P KTISVQQWNSYSGIL Q FPSAPTIDG V FLP D DPM E LMKTADLKDYDILMGNVRDEGTYFLYDFIDYDFDKDD P T P LPRDKYLEIMN E IF K KATQAEREAIIFQYTSWEGNPGYQNQQQIGRAVGD Y FF V CPTNE F TO THE MEN N V Y YYYFTHR S STSLWGEWMGVLHGDEIEYFFG L PLN P SL N Y T P E HUSBAND A CRM R AVIEFAKTGNPAQDGEEWP P FSKEDPVYYIFSTDDKIEKLARG L LA K RC A FWNDYLPKVRSWAGTCDGDSGSASISPRLQLLGIAALIYICAALRTKRVF;

[0070] Recombinant acetylcholinesterase sequence (SEQ ID NO.3):

[0071]

[0072] Example 2: Preparation of transformants expressing recombinant Drosophila acetylcholinesterase mutant

[0073] The recombinant vector obtained in Example 1 was transformed into host cells E. coli SHuffle T7, and single colonies were picked and inoculated into LB liquid medium (containing 100 μg / mL ampicillin) and cultured until the bacterial culture reached OD. 600 =0.6, add IPTG to a final concentration of 0.6 mmol / L, induce at 18℃ for 18 h, collect the bacterial pellet and sonicate, and detect the expression of the target protein by SDS-PAGE electrophoresis. It was found that the prepared transformant can efficiently express the recombinant Drosophila acetylcholinesterase mutant.

[0074] Example 3: Expression and identification of recombinant Drosophila acetylcholinesterase mutant in recombinant Escherichia coli

[0075] The positive transformant strain capable of expressing the recombinant Drosophila acetylcholinesterase mutant obtained in Example 2 was inoculated into 5 mL of LB liquid medium containing 100 μg / mL ampicillin and cultured overnight at 37°C with shaking. The seed culture obtained overnight was then inoculated into 500 mL of LB liquid medium containing 100 μg / mL ampicillin at a volume ratio of 1:100 and cultured again at 37°C with shaking until the bacterial culture reached OD. 600 =0.6; Add IPTG to each bottle of bacterial culture to a final concentration of 0.6 mmol / L, and continue to induce fermentation at 18℃ with shaking for 18 h; collect the induced bacterial cells by centrifugation and weigh the wet weight of the cells, and resuspend the bacterial pellet in lysis buffer (300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5). Disrupt the bacterial cells in an ice bath using an ultrasonic cell disruptor (total time 30 min, sonication 3 s, interval 3 s, power 150 W). Take 20 μL of the sonicated sample as the total protein after induction. Centrifuge the remaining bacterial culture at high speed (4℃, 12000 g, 30 min) to separate the supernatant precipitate, resuspend the precipitate in buffer, and collect 20 μL of supernatant and resuspended solution for SDS-PAGE analysis.

[0076] Protein expression status as follows Figure 1 As shown, the results indicate that there are obvious bands around the expected theoretical molecular weight in the total bacterial protein and precipitate, proving that the recombinant protein was expressed under the induction of IPTG.

[0077] Example 4: Purification of Recombinant Drosophila Acetylcholinesterase Mutant

[0078] (1) First, the recombinant bacterial cells were sonicated. The bacterial cells were resuspended in buffer solution (300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5) in a -20℃ frozen bacterial pellet. The cells were then lysed using an ultrasonic cell disruptor on ice. The sonication conditions were: total time 30 min, sonication time 3 s, interval 3 s, power 150 W. The lysed cells were then centrifuged at 12000 g for 30 min at 4℃ in a high-speed refrigerated centrifuge. The supernatant was filtered through a 0.22 μm microporous membrane and set aside.

[0079] (2) Next was nickel ion affinity chromatography. The chromatography column used for purification was a nickel ion affinity chromatography column (purchased from GE Healthcare). Affinity equilibration buffer A: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4, pH 7.5, filtered through a 0.22 μm filter membrane. Affinity elution buffer B: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4 and 500 mmol / L imidazole; pH 7.5, filtered through a 0.22 μm filter membrane.

[0080] (3) Connect the nickel ion affinity chromatography column to the column position valve of the rapid protein purification instrument, wash the system and column with ultrapure water, then equilibrate the column with binding buffer A, and then use the sample pump to load the supernatant described in step (1). After loading, first wash the column with buffer A to rinse away any proteins or impurities that have not bound to the column, and then elute with elution buffer B to collect the elution peak containing the target protein recombinant Drosophila acetylcholinesterase.

[0081] The elution peak was sampled and detected by SDS-PAGE protein electrophoresis. The results are as follows: Figure 2 As shown in the SDS-PAGE results, a large number of multi-component contaminating proteins were present in the permeate during the purification process, and the target protein band was almost invisible. This indicates that most of the target protein was bound to nickel ions. The eluent contained bands with molecular sizes similar to the target protein. Although the bands were faint, the purity was high.

[0082] Example 5 Activity test of recombinant Drosophila acetylcholinesterase mutant

[0083] The eluent collected in Example 4 was dialyzed for 12 h at 4°C using a 3500 Da dialysis bag in phosphate buffer (300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5). 128 μL of the dialyzed recombinant enzyme solution was added to a 96-well plate, followed by 32 μL of phosphate buffer. The mixture was thoroughly mixed and incubated at 37°C for 15 min. Immediately after incubation, 40 μL of Ellman substrate chromogenic solution (100 mmol / L NaH2PO4-Na2HPO4, 300 mmol / L NaCl, 1.25 mmol / L ATChI, 1.25 mmol / L DTNB; pH 7.5) was added to each well. After mixing, the plate was placed in a microplate reader, and colorimetric measurements were taken at 412 nm for 3 min, with readings every 30 s. The blank control was prepared by mixing 160 μL of phosphate equilibration buffer with 40 μL of Ellman substrate chromogenic solution.

[0084] The enzyme activity unit (U) is defined as follows: 1 U is the amount of 1 μmol of thiocholine produced in 1 min using ATChI as a substrate in an active buffer at a reaction temperature of 37°C.

[0085] The enzyme activity (U / mL) was calculated using the volume ratio of acetylcholinesterase, as shown in the following formula:

[0086]

[0087] Where: ΔOD 412 The value represents the change in absorbance at 412 nm by the microplate reader within 3 minutes. V is the total volume of the reaction system (mL), a is the dilution factor of AChE, and ε is the extinction coefficient, which is 1.36 x 10⁻⁶. 4 L·mol -1 ·cm -1 d is the optical path length (cm), T is the reaction time, and Ve is the volume of the enzyme solution in the reaction system (mL).

[0088] The enzyme activity and yield of the recombinant Drosophila acetylcholinesterase mutant in the purified eluent are shown in Table 1. The results showed that the specific activity of the purified recombinant enzyme was 203.66 U / mg, and the acetylcholinesterase activity expressed per liter of fermentation broth reached 147.36 U, approximately five times that of the wild type (28.73 U). The preparation of the wild-type acetylcholinesterase was performed according to Examples 1-4, with the amino acid sequence shown in SEQ ID NO.2. The nucleotide sequence was also codon-optimized, as shown in SEQ ID NO.4.

[0089] Table 1. Enzyme activity and yield of recombinant Drosophila acetylcholinesterase mutant purified by nickel ion affinity chromatography.

[0090]

[0091] Example 6: Optimal pH test of recombinant Drosophila acetylcholinesterase mutant

[0092] Small amounts of wild-type and mutant recombinant Drosophila acetylcholinesterase mutant enzyme solutions were dialyzed and incubated for 20 min in buffer solutions at pH 4.0, 5.0, 6.0, 7.0, 7.5, 8.0, and 9.0. Then, 160 μL of the enzyme solutions treated under the different pH conditions were added to a 96-well plate and incubated at 37°C for 15 min. After incubation, Ellman substrate chromogenic solution was added according to the method described in Example 5, and the activity was measured using a microplate reader. The highest activity under each pH condition was defined as 100%, and the relative enzyme activity under other pH conditions was calculated.

[0093] The effect of pH on the activity of recombinant Drosophila acetylcholinesterase, such as Figure 3 As shown in the figure. The results indicate that both wild-type and mutant recombinant enzymes exhibit good activity within the pH range of 6.0-9.0. At pH < 5.0, the activity of both is poor. As the pH increases, the activity of both tends to first increase and then decrease, reaching its highest activity at pH = 7.5. Therefore, the optimal pH for the Drosophila acetylcholinesterase mutant is not significantly different from that of the wild-type.

[0094] Example 7: Optimal Temperature Test of Recombinant Drosophila Acetylcholinesterase Mutant

[0095] Small amounts of wild-type and mutant recombinant Drosophila acetylcholinesterase mutant enzyme solutions were dialyzed and incubated for 15 min at temperatures of 25, 28, 32, 35, 37, 40, 43, 48, 53, 57, 62, 67, and 71 °C. Then, 160 μL of the enzyme solutions treated at the different temperatures was added to a 96-well plate, and Ellman substrate chromogenic solution was added according to the method described in Example 5. Activity was measured using a microplate reader. The highest activity at each of the above temperature conditions was defined as 100%, and the relative enzyme activity at other temperature conditions was calculated.

[0096] The effect of reaction temperature on the activity of recombinant Drosophila acetylcholinesterase, such as Figure 4 As shown in the figure. The results indicate that both wild-type and mutant recombinant enzymes exhibit good activity within the reaction temperature range of 25℃-50℃. Specifically, the activity increases with increasing temperature within the range of 25-37℃; the activity reaches its peak at 37℃; thereafter, the activity decreases with increasing temperature, and the enzyme tends to become inactive above 60℃. Therefore, the optimal temperature for the recombinant Drosophila acetylcholinesterase mutant is not significantly different from that of the wild type, remaining at 37℃.

[0097] Example 8: pH stability test of recombinant Drosophila acetylcholinesterase mutant

[0098] Small amounts of wild-type and mutant recombinant Drosophila acetylcholinesterase were dialyzed and mixed in buffer solutions at pH 4.0, 5.0, 6.0, 7.0, 7.5, 8.0, and 9.0, respectively. The solutions were incubated at 37°C for 2 hours. After incubation, Ellman substrate chromogenic solution was added according to the method described in Example 5, and the activity was measured using a microplate reader. The highest activity at each of the above pH conditions was defined as 100%, and the relative enzyme activity at other pH conditions was calculated.

[0099] The results are as follows Figure 5 As shown in the figure. The results indicate that both wild-type and mutant recombinant Drosophila acetylcholinesterase exhibit good activity within the pH range of 6.0-9.0, with the highest enzyme activity observed after incubation at pH 7.5, indicating that this condition is most favorable for preservation. When stored at pH < 6.0 or pH > 9.0, the activity decreases sharply. At pH ≤ 6 or pH = 9, the residual relative activity of the recombinant Drosophila acetylcholinesterase mutant is higher than that of the wild type, indicating a slight improvement in stability.

[0100] Example 9: Thermostability Test of Recombinant Drosophila Acetylcholinesterase Mutant

[0101] Small amounts of wild-type and mutant recombinant Drosophila acetylcholinesterase solutions were dialyzed and incubated for 2 hours at temperatures of 25, 28, 32, 35, 37, 40, 43, 48, 53, 57, 62, 67, and 71°C. After incubation, 160 μL of the enzyme solution at each temperature was added to a 96-well plate and incubated at 37°C for 15 minutes. Ellman substrate chromogenic solution was then added according to the method described in Example 5, and the activity was measured using a microplate reader. The highest activity at each temperature was defined as 100%, and the relative enzyme activity under the remaining conditions was calculated.

[0102] The results are as follows Figure 6 As shown in the figure. The results indicate that the activity of recombinant Drosophila acetylcholinesterase in both wild-type and mutant strains gradually decreases with increasing incubation temperature. When the temperature exceeds 50℃, the activity is significantly reduced, even to the point of inactivation. Notably, compared to the wild-type, the recombinant Drosophila acetylcholinesterase mutant exhibits a slightly higher residual relative enzyme activity and a minor improvement in thermal stability under high-temperature conditions.

[0103] Example 10 Storage stability test of Drosophila acetylcholinesterase mutant

[0104] Take a small amount of the newly prepared recombinant Drosophila acetylcholinesterase mutant enzyme solution after dialyzing and store it at -20℃. Every 6 days, take 160 μL and add it to a 96-well plate, incubate at 37℃ for 15 min. After incubation, add Ellman substrate chromogenic solution as described in Example 5 and measure enzyme activity. Calculate the remaining relative enzyme activity after storage, defining the initial activity as 100%.

[0105] The results are as follows Figure 7 As shown, the enzyme activity decreased with prolonged storage time, indicating that the enzyme has a shelf life; prolonged storage can lead to decreased activity or even inactivation. While the enzyme activity decreased during storage, after 6 weeks of storage at -20℃, the remaining enzyme activity was still close to 90%, demonstrating that the enzyme possesses a certain degree of storage stability under low-temperature conditions.

[0106] Example 11 Pesticide susceptibility testing of recombinant fruit fly acetylcholinesterase mutant

[0107] A small amount of stock solutions (100 μg / mL) of six pesticide standards—dimethoate, dichlorvos, malathion, trichlorfon, methomyl, and methamidophos—were added to phosphate buffer to prepare multiple gradient pesticide dilutions. A certain amount of commercially available acetylcholinesterase and recombinant acetylcholinesterase mutant were taken and, following the method described in Example 5, with the original phosphate buffer replaced by 32 μL of buffer containing different concentrations of pesticides, Ellman substrate chromogenic solution was added, and the activity was measured using a microplate reader. A blank control was prepared by mixing 128 μL of enzyme solution and 32 μL of phosphate buffer. The inhibition rate (I) of the pesticides was calculated by measuring the enzyme activity of various pesticides under different gradient conditions. The inhibition rate was calculated using the formula:

[0108]

[0109] E1 represents the enzyme activity in the blank control, and E2 represents the enzyme activity after pesticide inhibition. A linear curve was plotted with the common logarithm of the pesticide dilution concentration (lgc) on the x-axis and the inhibition rate (I) on the y-axis. The IC50 values ​​of various pesticides on the two acetylcholinesterases were then calculated. 50 The results are shown in Table 2. The results indicate that the six pesticides exhibited concentration-dependent effects on the two enzyme preparations; the higher the pesticide concentration, the lower the enzyme activity. The IC50 values ​​of the six pesticides on the two enzymes are also shown in Table 2. 50 The values ​​of the recombinant acetylcholinesterase mutant were all lower than those of the commercially available acetylcholinesterase. The recombinant acetylcholinesterase mutant is more sensitive to pesticides, and its detection limit for several pesticides is lower, making it more advantageous for detecting low-concentration pesticide residues. Therefore, the recombinant enzyme mutant is more sensitive than commercially available enzyme preparations and can be used for the detection of common pesticide residues.

[0110] Table 2 IC50 of various pesticides on acetylcholinesterase50 value

[0111]

[0112] The above embodiments are preferred embodiments of the present invention, but the embodiments of the present invention are not limited to the above embodiments. Any changes, modifications, substitutions, combinations, or simplifications made without departing from the spirit and principle of the present invention shall be considered equivalent substitutions and shall be included within the protection scope of the present invention.

Claims

1. A highly active recombinant acetylcholinesterase mutant, characterized in that: Its amino acid sequence is shown in SEQ ID NO.

1.

2. The biomaterial related to the recombinant acetylcholinesterase mutant as described in claim 1, characterized in that: It can be any one of the following biological materials: 1) The DNA molecule encoding the recombinant acetylcholinesterase mutant described above; 2) An expression cassette containing the DNA molecule described in 1); 3) A recombinant expression vector containing the DNA molecule described in 1); 4) Recombinant engineered cell lines containing the DNA molecules described in 1).

3. The biomaterial according to claim 2, characterized in that: The nucleotide sequence of the DNA molecule described in 1) is a sequence in which the codons have been optimized based on the E. coli expression system.

4. The method for preparing the highly active recombinant acetylcholinesterase mutant as described in claim 1, characterized in that: After transforming the recombinant expression vector containing the DNA molecule encoding the recombinant Drosophila acetylcholinesterase mutant into engineered cells, the cells were induced to express the mutant. The bacterial precipitate was collected by solid-liquid separation and purified to obtain a highly active recombinant Drosophila acetylcholinesterase mutant.

5. The preparation method according to claim 4, characterized in that: The nucleotide sequence of the DNA molecule is shown in SEQ ID NO.3; The backbone vector of the recombinant expression vector is a pET series vector; The engineered cells are Escherichia coli cells; The induced expression includes the following steps: (1) Take the recombinant engineered cell line, inoculate it into LB liquid medium and culture it to obtain the recombinant engineered cell seed solution; (2) The obtained seed culture was inoculated into LB liquid medium and cultured with shaking until the bacterial culture reached OD. 600 =0.6~0.8; (3) Add IPTG to the obtained bacterial culture to a final concentration of 0.05-1 mmol / L to induce the cells to express the target protein. Centrifuge and collect the bacterial precipitate. The obtained bacterial precipitate contains the recombinant acetylcholinesterase mutant. The purification process includes the following steps: (4) Add lysis buffer to the obtained bacterial pellet and shake to resuspend the bacterial pellet; (5) The obtained resuspension was ultrasonically treated and centrifuged to remove the precipitate, and the supernatant was obtained. (6) The supernatant was filtered using a microporous membrane with a pore size of 0.22 μm; (7) The target protein was purified by nickel ion affinity chromatography and the eluent was collected to obtain a highly active recombinant Drosophila acetylcholinesterase mutant.

6. The preparation method according to claim 5, characterized in that: The backbone vector of the recombinant expression vector is pET-32a; The engineered cells are SHuffle T7 cells; The LB liquid culture media mentioned above are all LB media containing 100 μg / mL ampicillin; The culture conditions described in step (1) are: overnight culture at 37°C with shaking; The ratio of the recombinant engineered cell seed solution and LB medium in step (2) is 1:100 by volume. The conditions for the shaking culture described in step (2) are a temperature of 35–38°C and a rotation speed of 150–200 r / min; The addition of IPTG to a final concentration of 0.05–1 mmol / L in step (3) refers to the addition of the inducing agent IPTG to a final concentration of 0.6 mmol / L. The induction conditions described in step (3) are induction at 18–37°C for 16–24 h; The centrifugation conditions described in step (3) are: centrifugation at 3000-5000g for 20-40 minutes at 4℃; The lysis buffer solution described in step (4) has the following composition: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.

5. The ratio of bacterial cell precipitation and lysis buffer in step (4) is 1g: 5-10mL by mass volume; the conditions for ultrasonic treatment in step (5) are 100-250W power, 1-4s ultrasonication, 1-4s interval, and 20-30min duration. The centrifugation conditions described in step (5) are: centrifugation at 10000-15000g for 20-40 minutes at 4℃; The equilibrium buffer solution used for nickel ion affinity chromatography in step (7) is formulated as follows: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4; pH 7.5; The elution buffer formulation for nickel ion affinity chromatography in step (7) is: 300 mmol / L NaCl, 100 mmol / L NaH2PO4-Na2HPO4 and 500 mmol / L imidazole; pH 7.

5.

7. The application of the highly active recombinant acetylcholinesterase mutant as described in claim 1 in pesticide residue detection, characterized in that: The pesticides mentioned are organophosphorus pesticides and / or carbamate pesticides.

8. The application according to claim 7, characterized in that: The detection is qualitative and / or quantitative.

9. The application according to claim 8, characterized in that: The application includes the following steps: adding the recombinant acetylcholinesterase mutant to the sample to be tested, incubating, adding Ellman substrate chromogenic solution after incubation, and measuring the activity with an enzyme-linked immunosorbent assay (ELISA) reader; by comparing the changes in enzyme activity before and after the reaction, the residual pesticide can be qualitatively and / or quantitatively detected. The incubation temperature is 37°C.